Advertisement
Review Article| Volume 16, ISSUE 1, P45-56, March 2023

Download started.

Ok

No Longer Well-Differentiated

Diagnostic Criteria and Clinical Importance of Poorly Differentiated/High-Grade Thyroid Carcinoma
Published:December 09, 2022DOI:https://doi.org/10.1016/j.path.2022.09.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baloch Z.W.
        • Asa S.L.
        • Barletta J.A.
        • et al.
        Overview of the 2022 WHO classification of thyroid neoplasms.
        Endocr Pathol. 2022; 33: 27-63
        • Gnemmi V.
        • Renaud F.
        • Do Cao C.
        • et al.
        Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features.
        Histopathology. 2014; 64: 263-273
        • Xu B.
        • Ghossein R.
        Poorly differentiated thyroid carcinoma.
        Semin Diagn Pathol. 2020; 37: 243-247
        • Hiltzik D.
        • Carlson D.L.
        • Tuttle R.M.
        • et al.
        Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
        Cancer. 2006; 106: 1286-1295
        • Asioli S.
        • Erickson L.A.
        • Righi A.
        • et al.
        Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.
        Mod Pathol. 2010; 23: 1269-1278
        • Wong K.S.
        • Lorch J.H.
        • Alexander E.K.
        • et al.
        Prognostic significance of extent of invasion in poorly differentiated thyroid carcinoma.
        Thyroid. 2019; 29: 1255-1261
        • Volante M.
        • Collini P.
        • Nikiforov Y.E.
        • et al.
        Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
        Am J Surg Pathol. 2007; 31: 1256-1264
        • Wong K.S.
        • Barletta J.A.
        Thyroid Tumors You Don't Want to Miss.
        Surg Pathol Clin. 2019; 12: 901-919
        • Wenig B.
        Neoplasms of the thyroid gland.
        in: Atlas of head and neck pathology. Elsevier, Philadelphia2016: 1381-1388
        • Cracolici V.
        • Kadri S.
        • Ritterhouse L.L.
        • et al.
        Clinicopathologic and molecular features of metastatic follicular thyroid carcinoma in patients presenting with a thyroid nodule versus a distant metastasis.
        Am J Surg Pathol. 2019; 43: 514-522
      1. Tallini G, Asa SL, Barletta JA, Kondo T, Lam AK, Piani S. Follicular-derived carcinomas, high-grade. In: Tallini G, editor. WHO Classification of Endocrine Tumors, 5th edition. 2023. Epub ahead of print: tumourclassification.iarc.who.int.

        • Wong K.S.
        • Dong F.
        • Telatar M.
        • et al.
        Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome.
        Thyroid. 2021; 31: 933-940
        • Baloch Z.W.
        • LiVolsi V.A.
        Special types of thyroid carcinoma.
        Histopathology. 2018; 72: 40-52
        • Nath M.C.
        • Erickson L.A.
        Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid.
        Adv Anat Pathol. 2018; 25: 172-179
        • Xu B.
        • David J.
        • Dogan S.
        • et al.
        Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
        Histopathology. 2022; 80: 322-337
        • Bai S.
        • Baloch Z.W.
        • Samulski T.D.
        • et al.
        Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
        Endocr Pathol. 2015; 26: 164-169
        • Dettmer M.
        • Schmitt A.
        • Steinert H.
        • et al.
        Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
        Histopathology. 2012; 60: 1045-1051
        • Lukovic J.
        • Petrovic I.
        • Liu Z.
        • et al.
        Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: clinical features, uptake, and response to radioactive iodine therapy, and outcome.
        Front Endocrinol (Lausanne). 2021; 12: 795184
        • Cancer Genome Atlas Research Network
        Integrated genomic characterization of papillary thyroid carcinoma.
        Cell. 2014; 159: 676-690
        • Volante M.
        • Lam A.K.
        • Papotti M.
        • et al.
        Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?.
        Endocr Pathol. 2021; 32: 63-76
        • Landa I.
        • Ibrahimpasic T.
        • Boucai L.
        • et al.
        Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
        J Clin Invest. 2016; 126: 1052-1066
        • Haroon Al Rasheed M.R.
        • Xu B.
        Molecular Alterations in Thyroid Carcinoma.
        Surg Pathol Clin. 2019; 12: 921-930
        • Ibrahimpasic T.
        • Ghossein R.
        • Shah J.P.
        • et al.
        Poorly differentiated carcinoma of the thyroid gland: current status and future prospects.
        Thyroid. 2019; 29: 311-321
        • Huang J.
        • Sun W.
        • Zhang Q.
        • et al.
        Clinicopathological characteristics and prognosis of poorly differentiated thyroid carcinoma diagnosed according to the turin criteria.
        Endocr Pract. 2021; 27: 401-407
        • Haugen B.R.
        • Alexander E.K.
        • Bible K.C.
        • et al.
        2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
        Thyroid. 2016; 26: 1-133
        • Papotti M.
        • Torchio B.
        • Grassi L.
        • et al.
        Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.
        Am J Surg Pathol. 1996; 20: 686-694
        • Rivera M.
        • Ghossein R.A.
        • Schoder H.
        • et al.
        Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
        Cancer. 2008; 113: 48-56
        • Xu B.
        • Ghossein R.
        Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
        Eur J Surg Oncol. 2018; 44: 338-347
        • Dettmer M.S.
        • Schmitt A.
        • Komminoth P.
        • et al.
        Poorly differentiated thyroid carcinoma : An underdiagnosed entity. Gering differenzierte Schilddrüsenkarzinome : Eine unterdiagnostizierte Entität.
        Pathologe. 2020; 41: 1-8
        • Dettmer M.
        • Schmitt A.
        • Steinert H.
        • et al.
        Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?.
        Am J Surg Pathol. 2011; 35: 1866-1872
        • Xu B.
        • Ibrahimpasic T.
        • Wang L.
        • et al.
        Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
        Thyroid. 2016; 26: 1588-1597
        • Patel K.N.
        • Shaha A.R.
        Poorly differentiated thyroid cancer.
        Curr Opin Otolaryngol Head Neck Surg. 2014; 22: 121-126
        • Chernock R.D.
        • Rivera B.
        • Borrelli N.
        • et al.
        Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations.
        Mod Pathol. 2020; 33: 1264-1274
        • Wasserman J.D.
        • Sabbaghian N.
        • Fahiminiya S.
        • et al.
        DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
        J Clin Endocrinol Metab. 2018; 103 ([published correction appears in J Clin Endocrinol Metab. 2018 Aug 1;103(8):3114]): 2009-2015
        • Ghossein C.A.
        • Dogan S.
        • Farhat N.
        • et al.
        Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
        Virchows Arch. 2022; 480: 293-302